Sinovac Covid-19 Vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023

Sinovac Covid-19 Vaccine

FILE PHOTO: An employee holds a vial containing CoronaVac, Sinovac Biotech's vaccine against the coronavirus disease (COVID-19), at Butantan biomedical production center in Sao Paulo, Brazil January 12, 2021. REUTERS/Amanda Perobelli
Coronavirus chronicle

China's Sinovac Covid-19 booster weaker against Omicron - Hong Kong study

Their analysis revealed Pfizer-BioNTech vaccine was more effective, as a third dose of the shot administered after two doses of the same or China's Sinovac vaccine provided "protective...

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

Brazil health regulator suspends use of 12 million Sinovac vaccine shots

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

North Korea turns down Sinovac Covid-19 vaccine doses

FILE PHOTO: A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter/File Photo
Coronavirus chronicle

Antibodies from Sinovac's Covid-19 shot fade after about 6 months, booster helps - study

A health worker prepares a dose of vaccine at Suvarnabhumi Airport, Bangkok, Thailand, April 5, 2021. Photo: Reuters
Coronavirus chronicle

Sinovac’s Covid-19 vaccine gains China approval for emergency use in children, adolescents

FILE PHOTO: A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter/File Photo
Coronavirus chronicle

WHO approves Sinovac Covid-19 vaccine, 2nd Chinese-made dose listed

FILE PHOTO: An employee holds a vial containing CoronaVac, Sinovac Biotech's vaccine against the coronavirus disease (COVID-19), at Butantan biomedical production center in Sao Paulo, Brazil January 12, 2021. REUTERS/Amanda Perobelli
Coronavirus chronicle

Chinese Sinovac shot seen as highly effective in real world study

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

EU drug regulator begins real-time review of Sinovac's Covid-19 vaccine

File Photo: A logo is pictured on the headquarters of the World Health Orgnaization (WHO) in Geneva, Switzerland, June 25, 2020. Photo: Reuters/Denis Balibouse
Coronavirus chronicle

WHO sets dates for reviews of Sinopharm and Sinovac Covid-19 vaccines

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

Egypt to produce up to 80 million Sinovac vaccine doses annually - minister

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

China Sinovac says it reached two billion doses annual capacity for Covid-19 vaccine

File Photo: A logo is pictured on the headquarters of the World Health Orgnaization (WHO) in Geneva, Switzerland, June 25, 2020. Photo: Reuters/Denis Balibouse
Coronavirus chronicle

Sinopharm, Sinovac Covid-19 vaccine data show efficacy - WHO

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. /Reuters
Coronavirus chronicle

Sinovac vaccine effective in children

  • Show More
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]